29
Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist QEH Gateshead

Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Embed Size (px)

Citation preview

Page 1: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Use of intra-operative frozen section in surgery for potential early stage

ovarian malignancy

September 2011Dr Paul Cross

Consultant Cellular PathologistQEH

Gateshead

Page 2: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Ovarian “cancer” - Clinical Problem• Want to try and diagnose as early as

possible to allow definitive surgical treatment (if this was applicable)

• Need tissue diagnosis to do so• Clinical discussion about possible use of

frozen section to help diagnose intra-operatively to prevent second procedure if possible

• Can diagnose and help stage in early stage disease

Page 3: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Frozen SectionsAdvantages

RapidAccurate (usually)Liked by surgeonsAre far more widely used elsewhere in the worldOne anaesthetic

DisadvantagesTime consuming (?)Costly (?)Stressful/?disliked by PathologistsNot that widely used in UK pathologyInaccurate (occasionally)

Page 4: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Why Gateshead?• Northern Gynaecological

Oncology Centre based at Gateshead

• Act as the Cancer Centre for women with Gynaecological malignancy for a population of approx 2,000,000 about 400 ovarian cancers/year

• High referral of cases of suspected ovarian malignancy (use of RMI >200)

Page 5: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Use of Ovarian Frozen Section Reporting

• Used in ovarian surgery to help decide if lesion is malignant or potentially malignant (borderline) or benign at the time of surgery

• If malignant or borderline then requires more tissue sampling to allow FIGO staging to assess possible extent of tumour involvement of other tissues

• If benign then requires no more surgery• QEH is, as far as is known, one of a few centres in

UK to routinely operate this ovarian FS service• Ovarian FS makes about 86% of all the FS we do

in our lab (n=195 for 2010)

Page 6: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Frozen Section Protocol• All cases are discussed prior to surgery in

MDT• Those with possible stage 1 or 2 ovarian

malignancy are put on theatre list for possible FS

• Laboratory are informed 24 hours in advance with details and approximate time

• Duty Pathologist (1 of 5) covers for FS• Porter brings directly to lab when available• FS processed (routinely 2 blocks) and

report phoned back to theatre

Page 7: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 8: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 9: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 10: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 11: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 12: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 13: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 14: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 15: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist
Page 16: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Frozen section reporting

Frozen section Paraffin section

Page 17: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

The iceberg principle…..

Page 18: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Table 1 Overall frozen section reporting profile n=1439

PS Benign PS Borderline PS Malignant

FS Benign769 39 19

FS Borderline

8 102 82

FS Malignant3 2 415

Page 19: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Table 2 Overall frozen section reporting, combining borderline and malignant categories n=1439

PS Benign PS Borderline/Malignant

FS Benign 769 58

FS Borderline/Malignant

11 601

Page 20: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Table 3 Primary ovarian epithelial tumours (serous, mucinous, endometrioid, clear cell, urothelial/Brenner) of the ovary at frozen section n=982

PS Benign PS Borderline PS Malignant

FS Benign 417 38 8

FS Borderline 8 97 74

FS Malignant 1 2 337

Page 21: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Summary - 1• Median time for reporting 20 minutes

(range 10-45, mean 18.5 minutes)• Overall specificity 98.6%• Overall sensitivity 91.2%• Lymphadenectomy rate 97.4% in

malignant epithelial cases• Overall metastasis to ovary from

elsewhere 4.8%, of which 77% were raised at the time of the FS

Page 22: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Summary - 2• Of the 1439 frozen sections reported here

(representing 1342 women), 94.5% of the women had the correct operative procedure at the initial surgical operation (that is staging or no-staging depending on the frozen section report).

• 4.3% of the women were under-staged at this first surgery, and required potentially a second procedure

• 1.2% of the women were over-staged based on the frozen section report

Page 23: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Summary - 3

• 19 false negatives(benign->malignant)– 7 interpretational errors– 12 sampling errors

• 3 false positive (malignant -> benign)– All interpretational errors

• Educational feedback always given after interpretational errors

• Sampling errors hard to fully eliminate

Page 24: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

FS by categoriesNo %

• Epithelial 982 68.4– Serous 486 33.8– Mucinous 267 18.6– Endometrioid 151 10.5– Clear Cell 58 4– Brenner 20 1.4

• Sex-Cord stromal 138 9.6• Germ cell 78 5.4• Secondary 69 4.8• Benign non-neoplastic 169 11.8

Page 25: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Summary - 4

• Overall sampling errors depend on size/weight and type of ovarian lesion

• False negative rate for serous lesions is 0.7% and is for mucinous tumours 3.8%

• These two epithelial types accounted for 52.4% of FS overall

• Surgeons understand higher inherent error rate with mucinous lesions

Page 26: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Literature Comparison of PPV

No Ben% Bl% M% Defer%

Rose et al 383 92 65 99.1 -Yeo et al 316 98.2 - 100 -Cuello et al 842 98.2 - 96.7 -Twallfhoven et al 946 92 62 100 -Obiakor et al 311 95.3 - 100 2.6Lim et al 215 98.4 - 100 -Usubuton et al 360 92.1 - 93.1 3.3Pinto et al 243 93 61 93Gateshead 1439 92.9 53.1 98.8 0.4

Page 27: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Pathology FS Cost• Require cryostat (which most/all labs have)• Require

– availability of lab staff (about 25 mins per FS case)

– availability of Pathologist (about 10 mins per FS case)

• Availability can depend on geography of lab/offices and rotas

• Not a difficult skill to acquire to interpret • Consumables –

slides/blades/cryofreeze/stains - pence

Page 28: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist

Conclusion

• Ovarian frozen section service does work clinically but needs regular material, good team work and communication

• Good outcomes and can confidently be used to help manage the clinical situation

• Trusted by clinicians, pathologists and patients – the vast majority of women are correctly treated at first procedure (94.5% overall, 98.2% in the BL/malignant group)

Page 29: Use of intra-operative frozen section in surgery for potential early stage ovarian malignancy September 2011 Dr Paul Cross Consultant Cellular Pathologist